Pre-earnings options volume in Soleno Therapeutics (SLNO) is 2.6x normal with calls leading puts 3:1. Implied volatility suggests the market is anticipating a move near 15.9%, or $10.45, after results are released. Median move over the past eight quarters is 3.1%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLNO:
- SLNO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Soleno not preannouncing Q3 sales ‘disappointing,’ says STAT’s Feuerstein
- Soleno Therapeutics rumor highlighted in Betaville alert
- Soleno Therapeutics Appoints Mark Hahn to Board
- Soleno Therapeutics appoints Hahn to its board of directors